1-1 of 1
Gabriel Daniel Duda, DMD, PhD
Close
Sort by
Journal Articles

Preclinical Rationale for the Use of Regorafenib in Myeloid Malignancies

Gabriela S. Hobbs, MD, Andrew M. Brunner, MD, Timothy A. Graubert, MD, Cyril H Benes, Gabriel Daniel Duda, DMD, PhD, Yi-Bin Chen, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2643.
https://doi.org/10.1182/blood.V130.Suppl_1.2643.2643
Published: 2017